Results 21 to 30 of about 49,093 (269)
Psoriasis is a skin disease that is characterized by a high degree of inflammation caused by immune dysfunction. (R)-salbutamol is a bronchodilator for asthma and was reported to alleviate immune system reactions in several diseases. In this study, using
Fei Liu+4 more
doaj +1 more source
BackgroundA combination of ipratropium bromide (IB) and salbutamol is commonly used to treat asthma in children and adolescents; however, there has been a lack of consistency in its usage in clinical practice.ObjectiveTo evaluate the efficacy and safety ...
Hongzhen Xu+6 more
doaj +1 more source
Introduction Many athletes use short-acting inhaled β2-agonists multiple times weekly during training sessions to prevent exercise-induced bronchoconstriction, but it is unclear if treatment impairs training outcomes.
Morten Hostrup+5 more
doaj +1 more source
Raman enhancement effect of different silver nanoparticles on salbutamol
Salbutamol is a β-adrenergic receptor agonist compound which has been abused as an animal growth promoter to improve carcass lean meat percentage. At present, the detection of salbutamol by SERS mostly uses gold colloid as substrate, which is expensive ...
Qinghui Guo, Yankun Peng, Kuanglin Chao
doaj
The effects of salbutamol in an experimental model with acute respiratory distress syndrome
Objective: To investigate salbutamol effects on histopathologic features of acute respiratory distress syndrome (ARDS). Methods: ARDS was designed in Wistar albino male rats, 250–300 g in weight, by intratracheal instillation of physiological saline ...
Sema Yilmaz+7 more
doaj +1 more source
The aim of the work is to conduct an analytical review of the results of preclinical studies of levosalbutamol. The review discusses the pharmacodynamic features of the R-stereoisomer of salbutamol in vitro.
A. G. Miroshnichenko+3 more
doaj +1 more source
The clinical effectiveness and cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation [PDF]
Background: This review examines the clinical effectiveness and cost-effectiveness of hand-held inhalers to deliver medication for the routine management of chronic asthma in children aged between 5 and 15 years.
Beverley, C.+4 more
core +1 more source
Drug–drug interactions (DDIs) represent a significant concern in healthcare, particularly for patients undergoing polytherapy. DDIs can lead to a range of outcomes, from decreased therapeutic effectiveness to adverse effects. Salbutamol, a bronchodilator
Lara Marques, Nuno Vale
doaj +1 more source
Salbutamol: beware of the paradox! [PDF]
A 7-year-old known asthmatic presented with an acute severe asthma attack to the Accident and Emergency department. Following a poor response to salbutamol and ipratropium nebulisers, he was given intravenous salbutamol and aminophylline. Over the course of the following 3 h, there was improvement in his bronchospasm with decreasing oxygen requirement,
R Saxena, G Marais
openaire +3 more sources
Anticholinergic therapy for acute asthma in children. [PDF]
Inhaled anticholinergics as single agent bronchodilators (or in combination with beta(2)-agonists) are one of the several medications available for the treatment of acute asthma in ...
Beakes+49 more
core +2 more sources